

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 9.92419844 |
| 2 | lymph node development (GO:0048535) | 7.92357640 |
| 3 | cytidine metabolic process (GO:0046087) | 6.64429311 |
| 4 | cytidine catabolic process (GO:0006216) | 6.64429311 |
| 5 | cytidine deamination (GO:0009972) | 6.64429311 |
| 6 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 6.48848271 |
| 7 | regulation of growth of symbiont in host (GO:0044126) | 6.48848271 |
| 8 | negative regulation of growth of symbiont in host (GO:0044130) | 6.48848271 |
| 9 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 6.48848271 |
| 10 | mast cell activation (GO:0045576) | 6.23995759 |
| 11 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 5.98551586 |
| 12 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.85599419 |
| 13 | positive regulation of B cell mediated immunity (GO:0002714) | 5.71239931 |
| 14 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 5.71239931 |
| 15 | regulation of response to tumor cell (GO:0002834) | 4.99235103 |
| 16 | positive regulation of response to tumor cell (GO:0002836) | 4.99235103 |
| 17 | positive regulation of immune response to tumor cell (GO:0002839) | 4.99235103 |
| 18 | regulation of immune response to tumor cell (GO:0002837) | 4.99235103 |
| 19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.95759144 |
| 20 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.93949767 |
| 21 | activated T cell proliferation (GO:0050798) | 4.91644055 |
| 22 | DNA deamination (GO:0045006) | 4.82201507 |
| 23 | protein neddylation (GO:0045116) | 4.41270505 |
| 24 | purine nucleotide salvage (GO:0032261) | 4.23733432 |
| 25 | regulation of immunoglobulin mediated immune response (GO:0002889) | 4.14268116 |
| 26 | hypotonic response (GO:0006971) | 4.10800640 |
| 27 | regulation of B cell mediated immunity (GO:0002712) | 4.09102966 |
| 28 | positive regulation of granulocyte differentiation (GO:0030854) | 4.00100706 |
| 29 | negative regulation of fibroblast proliferation (GO:0048147) | 3.89030822 |
| 30 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.88100971 |
| 31 | negative regulation of telomere maintenance (GO:0032205) | 3.67593168 |
| 32 | positive regulation of defense response to virus by host (GO:0002230) | 3.59117451 |
| 33 | tolerance induction (GO:0002507) | 3.57242803 |
| 34 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.49480851 |
| 35 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.48758237 |
| 36 | IMP biosynthetic process (GO:0006188) | 3.48714423 |
| 37 | leukocyte aggregation (GO:0070486) | 3.47178059 |
| 38 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.39613468 |
| 39 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.38594501 |
| 40 | negative thymic T cell selection (GO:0045060) | 3.38240245 |
| 41 | T cell homeostasis (GO:0043029) | 3.38090765 |
| 42 | autophagic vacuole fusion (GO:0000046) | 3.35822133 |
| 43 | cardiolipin metabolic process (GO:0032048) | 3.34746392 |
| 44 | mast cell degranulation (GO:0043303) | 3.32080159 |
| 45 | mast cell activation involved in immune response (GO:0002279) | 3.32080159 |
| 46 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.30590801 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.30190908 |
| 48 | negative T cell selection (GO:0043383) | 3.26790556 |
| 49 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.21385558 |
| 50 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.17312179 |
| 51 | regulation of humoral immune response (GO:0002920) | 3.13258446 |
| 52 | transcription from mitochondrial promoter (GO:0006390) | 3.12636049 |
| 53 | negative regulation of T cell apoptotic process (GO:0070233) | 3.12289193 |
| 54 | T cell migration (GO:0072678) | 3.08096214 |
| 55 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.06944724 |
| 56 | cellular response to interleukin-15 (GO:0071350) | 3.02304312 |
| 57 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.99939008 |
| 58 | positive regulation of B cell differentiation (GO:0045579) | 2.99747112 |
| 59 | positive T cell selection (GO:0043368) | 2.98824330 |
| 60 | T cell proliferation (GO:0042098) | 2.96386159 |
| 61 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.94901271 |
| 62 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.93755382 |
| 63 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.93567240 |
| 64 | positive regulation of adaptive immune response (GO:0002821) | 2.90689829 |
| 65 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.89290625 |
| 66 | regulation of granulocyte differentiation (GO:0030852) | 2.88948660 |
| 67 | neutrophil activation involved in immune response (GO:0002283) | 2.87594960 |
| 68 | positive regulation of interferon-gamma production (GO:0032729) | 2.87412332 |
| 69 | nucleoside transmembrane transport (GO:1901642) | 2.86059910 |
| 70 | positive regulation of leukocyte mediated immunity (GO:0002705) | 2.83932616 |
| 71 | IMP metabolic process (GO:0046040) | 2.82766682 |
| 72 | response to interleukin-15 (GO:0070672) | 2.82144526 |
| 73 | positive thymic T cell selection (GO:0045059) | 2.81848423 |
| 74 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.81165858 |
| 75 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.79676103 |
| 76 | maturation of SSU-rRNA (GO:0030490) | 2.77534522 |
| 77 | regulation of regulatory T cell differentiation (GO:0045589) | 2.77034560 |
| 78 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.76633620 |
| 79 | hepatocyte apoptotic process (GO:0097284) | 2.76532291 |
| 80 | necroptotic process (GO:0070266) | 2.76348330 |
| 81 | regulation of B cell differentiation (GO:0045577) | 2.74379472 |
| 82 | regulation of lymphocyte mediated immunity (GO:0002706) | 2.74054545 |
| 83 | regulation of alkaline phosphatase activity (GO:0010692) | 2.73366128 |
| 84 | NIK/NF-kappaB signaling (GO:0038061) | 2.72833748 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.69656145 |
| 86 | thymic T cell selection (GO:0045061) | 2.66853408 |
| 87 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.65690109 |
| 88 | organelle membrane fusion (GO:0090174) | 2.60517572 |
| 89 | B cell mediated immunity (GO:0019724) | 2.59028049 |
| 90 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.58297821 |
| 91 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.57146229 |
| 92 | negative regulation of cell killing (GO:0031342) | 2.56073225 |
| 93 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.56073225 |
| 94 | purine-containing compound salvage (GO:0043101) | 2.54870217 |
| 95 | pseudouridine synthesis (GO:0001522) | 2.54070626 |
| 96 | T cell selection (GO:0045058) | 2.52755409 |
| 97 | lymphocyte homeostasis (GO:0002260) | 2.52458685 |
| 98 | regulation of chronic inflammatory response (GO:0002676) | 12.4190292 |
| 99 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 11.8101893 |
| 100 | positive regulation of humoral immune response (GO:0002922) | 10.0129569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.56027972 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.29512241 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.04459115 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.95377784 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.54588935 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.51925318 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 3.15038536 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.07193401 |
| 9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.05883087 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.04680128 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.98853797 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.83238280 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.82080651 |
| 14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.76839689 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.66993619 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.52846730 |
| 17 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.50701942 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.44696277 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.37721659 |
| 20 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.33688577 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.29960190 |
| 22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29659026 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.23468106 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.20998307 |
| 25 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.19548668 |
| 26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.08428225 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.98401236 |
| 28 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.89699963 |
| 29 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85664630 |
| 30 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.84290292 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.81819724 |
| 32 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.80775542 |
| 33 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.80131420 |
| 34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72550637 |
| 35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.70752755 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.68739730 |
| 37 | GATA3_26560356_Chip-Seq_TH2_Human | 1.68599841 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.63866314 |
| 39 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.60664062 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 1.60505883 |
| 41 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.57883483 |
| 42 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.56842159 |
| 43 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.56202571 |
| 44 | MAF_26560356_Chip-Seq_TH1_Human | 1.53816491 |
| 45 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.47650160 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43810420 |
| 47 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.43154942 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34690099 |
| 49 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34549740 |
| 50 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34130243 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32891802 |
| 52 | MAF_26560356_Chip-Seq_TH2_Human | 1.30726635 |
| 53 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30151499 |
| 54 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.28502612 |
| 55 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.27544567 |
| 56 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.26893690 |
| 57 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.25650160 |
| 58 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.22603476 |
| 59 | MYC_22102868_ChIP-Seq_BL_Human | 1.21916767 |
| 60 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.21015270 |
| 61 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.20462771 |
| 62 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.19716632 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18696099 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17736607 |
| 65 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16459718 |
| 66 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.15862687 |
| 67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12616742 |
| 68 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12362349 |
| 69 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.11690272 |
| 70 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.11579175 |
| 71 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.11522753 |
| 72 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.11196131 |
| 73 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10943269 |
| 74 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.09900546 |
| 75 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.07283983 |
| 76 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.07219870 |
| 77 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06473071 |
| 78 | GATA3_26560356_Chip-Seq_TH1_Human | 1.03932920 |
| 79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01903035 |
| 80 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01386401 |
| 81 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.01058411 |
| 82 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00741231 |
| 83 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99493145 |
| 84 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98350089 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97480613 |
| 86 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.97028398 |
| 87 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.96072562 |
| 88 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.95227137 |
| 89 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95066160 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94173383 |
| 91 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.94148448 |
| 92 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.93568548 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92917258 |
| 94 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92344719 |
| 95 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90499420 |
| 96 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.88361041 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87403120 |
| 98 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.86516138 |
| 99 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.86009172 |
| 100 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.85416939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 6.02534230 |
| 2 | MP0000685_abnormal_immune_system | 5.82799953 |
| 3 | MP0009785_altered_susceptibility_to | 3.99405586 |
| 4 | MP0001501_abnormal_sleep_pattern | 3.73040418 |
| 5 | MP0003763_abnormal_thymus_physiology | 3.43518873 |
| 6 | MP0009764_decreased_sensitivity_to | 3.39862959 |
| 7 | MP0005671_abnormal_response_to | 3.36907667 |
| 8 | MP0005464_abnormal_platelet_physiology | 3.06736401 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.87136045 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.77293733 |
| 11 | MP0001800_abnormal_humoral_immune | 2.72731551 |
| 12 | MP0002405_respiratory_system_inflammati | 2.68406992 |
| 13 | MP0001533_abnormal_skeleton_physiology | 2.46218247 |
| 14 | MP0005165_increased_susceptibility_to | 2.22977908 |
| 15 | MP0000703_abnormal_thymus_morphology | 2.11684916 |
| 16 | MP0002398_abnormal_bone_marrow | 2.06050062 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.00877742 |
| 18 | MP0002452_abnormal_antigen_presenting | 1.96719100 |
| 19 | MP0002420_abnormal_adaptive_immunity | 1.96101934 |
| 20 | MP0002723_abnormal_immune_serum | 1.94606038 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 1.89655656 |
| 22 | MP0001819_abnormal_immune_cell | 1.89394366 |
| 23 | MP0005025_abnormal_response_to | 1.86624644 |
| 24 | MP0003724_increased_susceptibility_to | 1.81855749 |
| 25 | MP0003303_peritoneal_inflammation | 1.81373128 |
| 26 | MP0009697_abnormal_copulation | 1.77472073 |
| 27 | MP0000689_abnormal_spleen_morphology | 1.76606864 |
| 28 | MP0000716_abnormal_immune_system | 1.74326841 |
| 29 | MP0003866_abnormal_defecation | 1.73222047 |
| 30 | MP0001790_abnormal_immune_system | 1.68735694 |
| 31 | MP0005387_immune_system_phenotype | 1.68735694 |
| 32 | MP0002419_abnormal_innate_immunity | 1.65105421 |
| 33 | MP0002332_abnormal_exercise_endurance | 1.63141025 |
| 34 | MP0002722_abnormal_immune_system | 1.61522662 |
| 35 | MP0002429_abnormal_blood_cell | 1.56113890 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.50971603 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.46615552 |
| 38 | MP0009763_increased_sensitivity_to | 1.42075348 |
| 39 | MP0002254_reproductive_system_inflammat | 1.38390216 |
| 40 | MP0001348_abnormal_lacrimal_gland | 1.38191052 |
| 41 | MP0002139_abnormal_hepatobiliary_system | 1.36094360 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 1.30453978 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.30287157 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.28062486 |
| 45 | MP0001661_extended_life_span | 1.22997101 |
| 46 | MP0005448_abnormal_energy_balance | 1.22896964 |
| 47 | MP0003806_abnormal_nucleotide_metabolis | 1.22361670 |
| 48 | MP0005083_abnormal_biliary_tract | 1.20267506 |
| 49 | MP0005365_abnormal_bile_salt | 1.18660271 |
| 50 | MP0006082_CNS_inflammation | 1.17306887 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.16584507 |
| 52 | MP0004381_abnormal_hair_follicle | 1.15691858 |
| 53 | MP0008058_abnormal_DNA_repair | 1.14228238 |
| 54 | MP0008004_abnormal_stomach_pH | 1.12795946 |
| 55 | MP0002006_tumorigenesis | 1.11517297 |
| 56 | MP0008469_abnormal_protein_level | 1.10219183 |
| 57 | MP0001851_eye_inflammation | 1.09297092 |
| 58 | MP0009765_abnormal_xenobiotic_induced | 1.07824842 |
| 59 | MP0002876_abnormal_thyroid_physiology | 1.05224815 |
| 60 | MP0005390_skeleton_phenotype | 1.03902103 |
| 61 | MP0004084_abnormal_cardiac_muscle | 1.03148725 |
| 62 | MP0003045_fibrosis | 1.01849044 |
| 63 | MP0008872_abnormal_physiological_respon | 1.00807434 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 0.98965302 |
| 65 | MP0003646_muscle_fatigue | 0.93794471 |
| 66 | MP0001853_heart_inflammation | 0.91111905 |
| 67 | MP0002019_abnormal_tumor_incidence | 0.90298494 |
| 68 | MP0001663_abnormal_digestive_system | 0.87655466 |
| 69 | MP0005646_abnormal_pituitary_gland | 0.87231501 |
| 70 | MP0001765_abnormal_ion_homeostasis | 0.86654070 |
| 71 | MP0005310_abnormal_salivary_gland | 0.85894126 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 0.80606248 |
| 73 | MP0004043_abnormal_pH_regulation | 0.80563152 |
| 74 | MP0002396_abnormal_hematopoietic_system | 0.80249226 |
| 75 | MP0000343_altered_response_to | 0.79072277 |
| 76 | MP0004036_abnormal_muscle_relaxation | 0.77941610 |
| 77 | MP0004947_skin_inflammation | 0.77730369 |
| 78 | MP0005084_abnormal_gallbladder_morpholo | 0.77379355 |
| 79 | MP0004130_abnormal_muscle_cell | 0.77131591 |
| 80 | MP0003868_abnormal_feces_composition | 0.75763819 |
| 81 | MP0006035_abnormal_mitochondrial_morpho | 0.75754473 |
| 82 | MP0002998_abnormal_bone_remodeling | 0.74324069 |
| 83 | MP0000609_abnormal_liver_physiology | 0.74145035 |
| 84 | MP0001873_stomach_inflammation | 0.72606220 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 0.70388062 |
| 86 | MP0008775_abnormal_heart_ventricle | 0.68470991 |
| 87 | MP0000230_abnormal_systemic_arterial | 0.67134299 |
| 88 | MP0000598_abnormal_liver_morphology | 0.65441535 |
| 89 | MP0004142_abnormal_muscle_tone | 0.62907483 |
| 90 | MP0004510_myositis | 0.62033965 |
| 91 | MP0005647_abnormal_sex_gland | 0.61013876 |
| 92 | MP0001666_abnormal_nutrient_absorption | 0.60477714 |
| 93 | MP0005266_abnormal_metabolism | 0.59976717 |
| 94 | MP0003172_abnormal_lysosome_physiology | 0.57857848 |
| 95 | MP0001542_abnormal_bone_strength | 0.56154501 |
| 96 | MP0003638_abnormal_response/metabolism_ | 0.55218553 |
| 97 | MP0010329_abnormal_lipoprotein_level | 0.54368311 |
| 98 | MP0010094_abnormal_chromosome_stability | 0.52362688 |
| 99 | MP0001944_abnormal_pancreas_morphology | 0.52288784 |
| 100 | MP0003786_premature_aging | 0.52228348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 5.43170156 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.57476446 |
| 3 | Prolonged bleeding time (HP:0003010) | 3.96730369 |
| 4 | Severe combined immunodeficiency (HP:0004430) | 3.91175764 |
| 5 | Generalized aminoaciduria (HP:0002909) | 3.87275764 |
| 6 | IgG deficiency (HP:0004315) | 3.72318226 |
| 7 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.69940181 |
| 8 | Recurrent cutaneous fungal infections (HP:0011370) | 3.69940181 |
| 9 | Purpura (HP:0000979) | 3.68581458 |
| 10 | Abnormal pupillary function (HP:0007686) | 3.67175662 |
| 11 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.59300757 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.57770791 |
| 13 | Stomatitis (HP:0010280) | 3.50485679 |
| 14 | Papilledema (HP:0001085) | 3.48759615 |
| 15 | Increased hepatocellular lipid droplets (HP:0006565) | 3.26292533 |
| 16 | Chronic hepatic failure (HP:0100626) | 3.20955695 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 3.10396107 |
| 18 | Combined immunodeficiency (HP:0005387) | 3.08672788 |
| 19 | T lymphocytopenia (HP:0005403) | 3.05651547 |
| 20 | Eosinophilia (HP:0001880) | 3.05440485 |
| 21 | Increased intramyocellular lipid droplets (HP:0012240) | 2.99525479 |
| 22 | Abnormality of eosinophils (HP:0001879) | 2.96857373 |
| 23 | Entropion (HP:0000621) | 2.93534347 |
| 24 | Renal Fanconi syndrome (HP:0001994) | 2.90621630 |
| 25 | B lymphocytopenia (HP:0010976) | 2.88408023 |
| 26 | Menorrhagia (HP:0000132) | 2.87899969 |
| 27 | Nausea (HP:0002018) | 2.87618214 |
| 28 | Paralysis (HP:0003470) | 2.85911076 |
| 29 | Thyroiditis (HP:0100646) | 2.85774920 |
| 30 | Epistaxis (HP:0000421) | 2.80402046 |
| 31 | Lipid accumulation in hepatocytes (HP:0006561) | 2.80384994 |
| 32 | Aplastic anemia (HP:0001915) | 2.72763837 |
| 33 | Exercise-induced myalgia (HP:0003738) | 2.70743720 |
| 34 | Recurrent bronchitis (HP:0002837) | 2.69654329 |
| 35 | Palpitations (HP:0001962) | 2.69180738 |
| 36 | Renal cortical cysts (HP:0000803) | 2.68821044 |
| 37 | Agammaglobulinemia (HP:0004432) | 2.67304545 |
| 38 | Granulocytopenia (HP:0001913) | 2.65461580 |
| 39 | Abnormality of T cell number (HP:0011839) | 2.63241873 |
| 40 | Type 2 muscle fiber atrophy (HP:0003554) | 2.63026653 |
| 41 | Abnormal platelet volume (HP:0011876) | 2.62693433 |
| 42 | Dyschromatopsia (HP:0007641) | 2.60399672 |
| 43 | Increased mean platelet volume (HP:0011877) | 2.60092328 |
| 44 | Recurrent viral infections (HP:0004429) | 2.58912445 |
| 45 | Lymphopenia (HP:0001888) | 2.56007143 |
| 46 | Acute encephalopathy (HP:0006846) | 2.55333101 |
| 47 | Increased muscle lipid content (HP:0009058) | 2.50438189 |
| 48 | Abnormality of B cell number (HP:0010975) | 2.49393381 |
| 49 | Encephalitis (HP:0002383) | 2.47396836 |
| 50 | Eczematoid dermatitis (HP:0000976) | 2.47191325 |
| 51 | Posterior subcapsular cataract (HP:0007787) | 2.46295890 |
| 52 | Glucose intolerance (HP:0000833) | 2.45629914 |
| 53 | Congenital, generalized hypertrichosis (HP:0004540) | 2.45011210 |
| 54 | Muscle fiber atrophy (HP:0100295) | 2.44883700 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 2.42081387 |
| 56 | Leukocytosis (HP:0001974) | 2.39434875 |
| 57 | Gingival bleeding (HP:0000225) | 2.39196655 |
| 58 | Abnormality of T cells (HP:0002843) | 2.38788936 |
| 59 | Oral leukoplakia (HP:0002745) | 2.38667145 |
| 60 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.35622280 |
| 61 | Increased IgE level (HP:0003212) | 2.34680530 |
| 62 | IgM deficiency (HP:0002850) | 2.34449658 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.28495379 |
| 64 | Lymphoma (HP:0002665) | 2.26762215 |
| 65 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.24174566 |
| 66 | Exertional dyspnea (HP:0002875) | 2.22245286 |
| 67 | Nemaline bodies (HP:0003798) | 2.18907772 |
| 68 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.18718561 |
| 69 | Chronic otitis media (HP:0000389) | 2.15814384 |
| 70 | Joint swelling (HP:0001386) | 2.12708622 |
| 71 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.08417485 |
| 72 | Tinnitus (HP:0000360) | 2.06856621 |
| 73 | Abnormality of the fingertips (HP:0001211) | 2.03999056 |
| 74 | Increased IgM level (HP:0003496) | 2.03955648 |
| 75 | Muscle fiber inclusion bodies (HP:0100299) | 2.00270014 |
| 76 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.00252042 |
| 77 | Late onset (HP:0003584) | 1.99993571 |
| 78 | Submucous cleft hard palate (HP:0000176) | 1.99696530 |
| 79 | Rough bone trabeculation (HP:0100670) | 1.99598945 |
| 80 | Acute necrotizing encephalopathy (HP:0006965) | 1.98240877 |
| 81 | Limb hypertonia (HP:0002509) | 1.98104723 |
| 82 | Hypoglycemic coma (HP:0001325) | 1.98094056 |
| 83 | Abnormal spermatogenesis (HP:0008669) | 1.96902760 |
| 84 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.95495726 |
| 85 | Chorioretinal atrophy (HP:0000533) | 1.94399214 |
| 86 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.94114131 |
| 87 | Osteolytic defects of the hand bones (HP:0009699) | 1.94114131 |
| 88 | Nasal polyposis (HP:0100582) | 1.93055147 |
| 89 | Cerebral hypomyelination (HP:0006808) | 1.92231138 |
| 90 | Acute hepatic failure (HP:0006554) | 1.91754576 |
| 91 | Neuroendocrine neoplasm (HP:0100634) | 1.90471426 |
| 92 | Mitochondrial inheritance (HP:0001427) | 1.87188733 |
| 93 | Verrucae (HP:0200043) | 1.86655154 |
| 94 | Papilloma (HP:0012740) | 1.86655154 |
| 95 | Keratoconjunctivitis (HP:0001096) | 1.85494914 |
| 96 | Chronic diarrhea (HP:0002028) | 1.85482119 |
| 97 | Pigmentary retinal degeneration (HP:0001146) | 1.84748199 |
| 98 | Hypoplasia of the thymus (HP:0000778) | 1.84298021 |
| 99 | Abnormality of methionine metabolism (HP:0010901) | 1.82595993 |
| 100 | Episodic fever (HP:0001954) | 1.82100071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.51228927 |
| 2 | EIF2AK1 | 3.69587100 |
| 3 | NME2 | 3.63889956 |
| 4 | TXK | 3.28119543 |
| 5 | RIPK4 | 3.20486616 |
| 6 | MST4 | 2.85256761 |
| 7 | MAP4K1 | 2.79525311 |
| 8 | TNK2 | 2.44258252 |
| 9 | EIF2AK3 | 2.32529666 |
| 10 | KIT | 2.28845137 |
| 11 | GRK6 | 2.14641075 |
| 12 | IKBKB | 2.02711570 |
| 13 | NLK | 2.01655505 |
| 14 | SYK | 2.01170855 |
| 15 | SMG1 | 1.93867366 |
| 16 | ZAP70 | 1.93815359 |
| 17 | FES | 1.89206088 |
| 18 | TLK1 | 1.88959898 |
| 19 | BLK | 1.85815986 |
| 20 | TAOK3 | 1.79424659 |
| 21 | STK16 | 1.78902183 |
| 22 | BTK | 1.72243399 |
| 23 | ADRBK2 | 1.70614619 |
| 24 | WNK1 | 1.64213602 |
| 25 | VRK1 | 1.63794483 |
| 26 | CAMKK2 | 1.57098398 |
| 27 | WNK4 | 1.54284145 |
| 28 | IKBKE | 1.51229292 |
| 29 | MAP3K11 | 1.45775765 |
| 30 | BUB1 | 1.41363121 |
| 31 | PIK3CG | 1.40404737 |
| 32 | TYK2 | 1.35028401 |
| 33 | OBSCN | 1.31770536 |
| 34 | MAPKAPK3 | 1.30244048 |
| 35 | TEC | 1.26935879 |
| 36 | NEK6 | 1.24279798 |
| 37 | ITK | 1.24119665 |
| 38 | LYN | 1.18484328 |
| 39 | MAPK11 | 1.11210129 |
| 40 | TRIM28 | 1.10326592 |
| 41 | PHKG1 | 0.98785523 |
| 42 | PHKG2 | 0.98785523 |
| 43 | CSF1R | 0.97514371 |
| 44 | EIF2AK2 | 0.96872365 |
| 45 | PTK2B | 0.95965655 |
| 46 | JAK3 | 0.95711169 |
| 47 | MAP3K14 | 0.94665733 |
| 48 | HCK | 0.93717247 |
| 49 | LCK | 0.92976449 |
| 50 | MYLK | 0.91953572 |
| 51 | CSK | 0.91824374 |
| 52 | DAPK2 | 0.90562952 |
| 53 | CLK1 | 0.84765199 |
| 54 | IRAK4 | 0.79933652 |
| 55 | BMX | 0.75842492 |
| 56 | MAPK13 | 0.74503553 |
| 57 | PAK4 | 0.74009657 |
| 58 | KDR | 0.73741208 |
| 59 | NUAK1 | 0.73256260 |
| 60 | PBK | 0.73091984 |
| 61 | NME1 | 0.71015483 |
| 62 | PRKCQ | 0.70223579 |
| 63 | DAPK1 | 0.66521800 |
| 64 | SCYL2 | 0.62737349 |
| 65 | BCKDK | 0.60773215 |
| 66 | JAK1 | 0.59898898 |
| 67 | MAPK12 | 0.59850313 |
| 68 | MAP3K1 | 0.55392568 |
| 69 | TSSK6 | 0.54998419 |
| 70 | GRK5 | 0.54091519 |
| 71 | CDK7 | 0.52917601 |
| 72 | MAP3K12 | 0.52609656 |
| 73 | ACVR1B | 0.46968481 |
| 74 | MAP2K6 | 0.45297369 |
| 75 | IRAK3 | 0.42291584 |
| 76 | TESK2 | 0.41199048 |
| 77 | ABL2 | 0.39868909 |
| 78 | PLK1 | 0.38071203 |
| 79 | HIPK2 | 0.37731591 |
| 80 | IRAK1 | 0.37594733 |
| 81 | PRKCI | 0.37506713 |
| 82 | IGF1R | 0.37064058 |
| 83 | PDK1 | 0.36297832 |
| 84 | ILK | 0.36206664 |
| 85 | CAMKK1 | 0.36058235 |
| 86 | WNK3 | 0.33405018 |
| 87 | CAMK2A | 0.32488673 |
| 88 | JAK2 | 0.31423860 |
| 89 | STK4 | 0.30198822 |
| 90 | TTN | 0.29022893 |
| 91 | PIM2 | 0.28977306 |
| 92 | EPHA3 | 0.28529946 |
| 93 | CHUK | 0.28263020 |
| 94 | PAK1 | 0.27372736 |
| 95 | PRKG1 | 0.26813865 |
| 96 | FGR | 0.25162503 |
| 97 | DAPK3 | 0.24069590 |
| 98 | ALK | 0.23753209 |
| 99 | ADRBK1 | 0.23253024 |
| 100 | MELK | 0.21963712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.43467869 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.43330738 |
| 3 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 4.35314337 |
| 4 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.87588117 |
| 5 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.69863284 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.64203735 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.55328732 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.18349360 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.17668216 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.16302354 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.08297493 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.05954935 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.79237246 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.75089243 |
| 15 | Platelet activation_Homo sapiens_hsa04611 | 1.66831852 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.64328721 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 1.60718084 |
| 18 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.54497672 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.53386327 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.50702497 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.49721029 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.48338956 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.45113766 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.35266120 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34306221 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.33662478 |
| 27 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.33526718 |
| 28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.32100996 |
| 29 | Spliceosome_Homo sapiens_hsa03040 | 1.26998569 |
| 30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.26017729 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.21397935 |
| 32 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.20790205 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19776548 |
| 34 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.15590537 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.07039059 |
| 36 | Sulfur relay system_Homo sapiens_hsa04122 | 1.02575545 |
| 37 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.02481613 |
| 38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.99551863 |
| 39 | Asthma_Homo sapiens_hsa05310 | 0.98175923 |
| 40 | RNA degradation_Homo sapiens_hsa03018 | 0.97723423 |
| 41 | Ribosome_Homo sapiens_hsa03010 | 0.96792112 |
| 42 | RNA polymerase_Homo sapiens_hsa03020 | 0.92419548 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.90414615 |
| 44 | HTLV-I infection_Homo sapiens_hsa05166 | 0.90238675 |
| 45 | Leishmaniasis_Homo sapiens_hsa05140 | 0.89711987 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.88018092 |
| 47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.83491177 |
| 48 | Purine metabolism_Homo sapiens_hsa00230 | 0.76826549 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 0.76408616 |
| 50 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76038048 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.72618993 |
| 52 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72538848 |
| 53 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.70721968 |
| 54 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.69014256 |
| 55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68894153 |
| 56 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.67853852 |
| 57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67162868 |
| 58 | Alzheimers disease_Homo sapiens_hsa05010 | 0.66262188 |
| 59 | Huntingtons disease_Homo sapiens_hsa05016 | 0.63969922 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63453633 |
| 61 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.56940991 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.55497256 |
| 63 | Malaria_Homo sapiens_hsa05144 | 0.55347352 |
| 64 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.53128822 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 0.52833059 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50663579 |
| 67 | Mismatch repair_Homo sapiens_hsa03430 | 0.50553290 |
| 68 | Legionellosis_Homo sapiens_hsa05134 | 0.48309607 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43113425 |
| 70 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41629602 |
| 71 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.40930060 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.40189129 |
| 73 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.38983992 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.38810061 |
| 75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38309119 |
| 76 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.37742343 |
| 77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.36254294 |
| 78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32180984 |
| 79 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.32058148 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31308369 |
| 81 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.30633203 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.30449532 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.30062396 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.29591371 |
| 85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29483794 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.28852548 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.25708082 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.25268930 |
| 89 | Influenza A_Homo sapiens_hsa05164 | 0.25025862 |
| 90 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.24689887 |
| 91 | Apoptosis_Homo sapiens_hsa04210 | 0.22695459 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.22202938 |
| 93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.22058698 |
| 94 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.21901741 |
| 95 | Basal transcription factors_Homo sapiens_hsa03022 | 0.20847811 |
| 96 | Phototransduction_Homo sapiens_hsa04744 | 0.20320924 |
| 97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.20138478 |
| 98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.19570496 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.18363995 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | 0.18011409 |

